期刊
BIOMEDICINES
卷 10, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines10123098
关键词
childhood cancer survivors; metabolic syndrome; diabetes; insulin resistance; hypertension; dyslipidemia; abdominal radiation; chemotherapy; metabolic derangements
资金
- Italian Ministry of Education-University of Chieti, Chieti, Italy
- [FAR-2020]
Cancer is a leading cause of death among children worldwide, and while survival rates have improved, survivors are at risk of metabolic abnormalities that may increase the risk of cardiovascular disease and premature mortality. Further research is needed to understand and improve long-term cardiometabolic outcomes for these patients.
Cancer is a prominent cause of death worldwide in the pediatric population. Since childhood cancer is not possible to prevent, it is essential to focus on a prompt and correct diagnosis followed by effective, evidence-based therapy with individualized supportive care. Given the enhancement of childhood cancer management over the past decades, survival rate has significantly improved, thus leading to the progression of several late effects, including metabolic derangements. These metabolic imbalances are associated with the underlying disease and the cancer treatments. As a result, the metabolic state may contribute to a high risk of cardiovascular morbidity and premature mortality among childhood cancer survivors. This review aims to summarize the potential pathophysiological mechanisms linked to the risk of diabetes and metabolic syndrome and screening recommendations. Further investigations are needed to clarify the underlying mechanisms of such metabolic abnormalities and to improve long-term cardiometabolic survival among these patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据